Scientists develop a high-throughput, cell-free screening platform for anti-SARS-CoV-2 antibody discovery

By | November 9, 2021
Scientists from Northwestern University, USA, have recently developed a high-throughput, automated screening platform to rapidly identify anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies. The study is currently available on the bioRxiv* preprint server.